Molecular Partners AG (MOLN) Stock Price, Quote, News & History

MOLNNASDAQ
$4.13
Last update: Aug 11, 4:00 AM
Earnings: Q2 2026 Earnings in 13 days from now on Tue Aug 25th, after the market close

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-48.42M
Investing Cash Flow (TTM)
33.66M
Financing Cash Flow (TTM)
-1.14M
Free Cash Flow (TTM)
-48.69M
Capital Expenditure (TTM)
-
Net Change in Cash (TTM)
-15.90M

Analyst Trends and Forecast

1
Mar
1
Apr
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
3.9
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$58.79M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
-
PB Ratio (TTM)
1.83
Earnings Yield % (TTM)
-46.43%
Earnings Yield % (FWD)
-43.74%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$2.26

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-$1.21M
Total Cash
$64.25M
Debt to Equity
0.05
Issuance of Debt (TTM)
-$1.21M
Repayment of Debt (TTM)
-$1.21M

Key Statistics

Open
-
Close
-
Volume / Avg.
14.00 / 6.57K
Day Range
- - -
52 Wk Range
3.46 - 5.36
Market Cap
$154.46M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
56
Short Interest
-
Days to Cover
1.75

About

Sector
Health Care
Industry
Biotechnology
Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeuti...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Molecular Partners (MOLN) stock?

A

You can purchase shares of Molecular Partners (NASDAQ:MOLN) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Molecular Partners (MOLN) competitors?

Q

What is the forecast, or price target, for Molecular Partners (MOLN) stock?

A

Molecular Partners has a consensus price target of $9.58.

Q

What is the current price for Molecular Partners (MOLN)?

A

The stock price for Molecular Partners (NASDAQ: MOLN) is $4.13 last updated August 11, 2026 at 4:00 AM EDT.

Q

Does Molecular Partners (MOLN) pay a dividend?

A

There are no upcoming dividends for Molecular Partners.

Q

When is Molecular Partners (NASDAQ:MOLN) reporting earnings?

A

Molecular Partners does not have any upcoming earnings scheduled.

Q

Is Molecular Partners (MOLN) going to split?

A

There is no upcoming split for Molecular Partners.

Q

What sector and industry does Molecular Partners (MOLN) operate in?

A

Molecular Partners is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.